Works matching AU King, Rebecca L.


Results: 60
    1
    2

    Molecular Features of Diffuse Large B‐Cell Lymphoma Associated With Primary Treatment Resistance.

    Published in:
    Hematological Oncology, 2025, v. 43, n. 1, p. 1, doi. 10.1002/hon.70006
    By:
    • Bock, Allison M.;
    • Wenzl, Kerstin;
    • Novak, Joseph P.;
    • Stokes, Matthew E.;
    • Hopper, Melissa A.;
    • Krull, Jordan E.;
    • Dropik, Abigail R.;
    • Sarangi, Vivek;
    • Ortiz, Maria;
    • Stong, Nicholas;
    • Huang, C. Chris;
    • Maurer, Matthew J.;
    • King, Rebecca L.;
    • Farooq, Umar;
    • Wang, Yucai;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Gandhi, Anita K.
    Publication type:
    Article
    3
    4

    Disease outcomes and biomarkers of progression in smouldering Waldenström macroglobulinaemia.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 2, p. 210, doi. 10.1111/bjh.17691
    By:
    • Zanwar, Saurabh;
    • Abeykoon, Jithma P.;
    • Ansell, Stephen M.;
    • Gertz, Morie A.;
    • Colby, Colin;
    • Larson, Dirk;
    • Paludo, Jonas;
    • He, Rong;
    • Warsame, Rahma;
    • Greipp, Patricia T.;
    • King, Rebecca L.;
    • Thompson, Carrie A.;
    • Witzig, Thomas E.;
    • Lacy, Martha Q.;
    • Gonsalves, Wilson;
    • Nowakowski, Grzegorz S.;
    • Dingli, David;
    • Go, Ronald S.;
    • Habermann, Thomas M.;
    • Vincent Rajkumar, S.
    Publication type:
    Article
    5
    6
    7

    Incidence of Central Nervous System Relapse in Primary Mediastinal Large B-Cell Lymphoma: Implications for Central Nervous System Prophylaxis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 2, p. 116, doi. 10.1016/j.clml.2024.07.019
    By:
    • Okcu, Izel;
    • Yucai Wang;
    • Bock, Allison M.;
    • Jihao Zhou;
    • Moustafa, Muhamad Alhaj;
    • Tun, Han W.;
    • Rosenthal, Allison C.;
    • Johnston, Patrick B.;
    • Baidoun, Firas;
    • Khurana, Arushi;
    • Kabat, Brian F.;
    • King, Rebecca L.;
    • Habermann, Thomas M.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    8
    9
    10
    11

    Morphologically Occult Systemic Mastocytosis in Bone Marrow.

    Published in:
    American Journal of Clinical Pathology, 2015, v. 144, n. 3, p. 493, doi. 10.1309/AJCPSGQ71GJQQACL
    By:
    • Reichard, Kaaren K.;
    • Dong Chen;
    • Pardanani, Animesh;
    • McClure, Rebecca F.;
    • Howard, Matthew T.;
    • Kurtin, Paul J.;
    • Wood, Adam J.;
    • Ketterling, Rhett P.;
    • King, Rebecca L.;
    • Rong He;
    • Morice, William G.;
    • Hanson, Curtis A.
    Publication type:
    Article
    12

    IgM Multiple Myeloma.

    Published in:
    American Journal of Clinical Pathology, 2013, v. 140, n. 4, p. 519, doi. 10.1309/AJCP0N7IELYUNJGZ
    By:
    • King, Rebecca L.;
    • Howard, Matthew T.;
    • Hodnefield, Janice M.;
    • Morice, William G.
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Bendamustine and rituximab (BR) versus dexamethasone, rituximab, and cyclophosphamide (DRC) in patients with Waldenström macroglobulinemia.

    Published in:
    2018
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Shreders, Amanda;
    • Ansell, Stephen M.;
    • Kumar, Shaji;
    • Ailawadhi, Sikander;
    • King, Rebecca L.;
    • Koehler, Amber B.;
    • Reeder, Craig B.;
    • Buadi, Francis K.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Dingli, David;
    • Witzig, Thomas E.;
    • Go, Ronald S.;
    • Gonsalves, Wilson I.;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Leung, Nelson;
    • Habermann, Thomas M.
    Publication type:
    journal article
    24
    25
    26

    Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50830-y
    By:
    • Stokes, Matthew E.;
    • Wenzl, Kerstin;
    • Huang, C. Chris;
    • Ortiz, María;
    • Hsu, Chih-Chao;
    • Maurer, Matthew J.;
    • Stong, Nicholas;
    • Nakayama, Yumi;
    • Wu, Lei;
    • Chiu, Hsiling;
    • Polonskaia, Ann;
    • Danziger, Samuel A.;
    • Towfic, Fadi;
    • Parker, Joel;
    • King, Rebecca L.;
    • Link, Brian K.;
    • Slager, Susan L.;
    • Sarangi, Vivekananda;
    • Asmann, Yan W.;
    • Novak, Joseph P.
    Publication type:
    Article
    27

    Response to erythropoiesis‐stimulating agents in patients with WHO‐defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T).

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 3, p. e104, doi. 10.1111/bjh.16515
    By:
    • Antelo, Guadalupe;
    • Mangaonkar, Abhishek A.;
    • Coltro, Giacomo;
    • Buradkar, Ajinkya;
    • Lasho, Terra L.;
    • Finke, Christy;
    • Carr, Ryan;
    • Binder, Moritz;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Elliott, Michelle A.;
    • King, Rebecca L.;
    • Howard, Matthew;
    • Melody, Megan E.;
    • Hogan, William;
    • Litzow, Mark R;
    • Tefferi, Ayalew;
    • Fernandez‐Zapico, Martin E.;
    • Komrokji, Rami;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    28

    Dexamethasone, rituximab and cyclophosphamide for relapsed and/or refractory and treatment-naïve patients with Waldenstrom macroglobulinemia.

    Published in:
    British Journal of Haematology, 2017, v. 179, n. 1, p. 98, doi. 10.1111/bjh.14826
    By:
    • Paludo, Jonas;
    • Abeykoon, Jithma P.;
    • Kumar, Shaji;
    • Shreders, Amanda;
    • Ailawadhi, Sikander;
    • Gertz, Morie A.;
    • Kourelis, Taxiarchis;
    • King, Rebecca L.;
    • Reeder, Craig B.;
    • Leung, Nelson;
    • Kyle, Robert A.;
    • Buadi, Francis K.;
    • Habermann, Thomas M.;
    • Dingli, David;
    • Witzig, Thomas E.;
    • Dispenzieri, Angela;
    • Lacy, Martha Q.;
    • Go, Ronald S.;
    • Lin, Yi;
    • Gonsalves, Wilson I.
    Publication type:
    Article
    29

    Risk of lymphoid malignancy associated with cancer predisposition genes.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01283-z
    By:
    • Boddicker, Nicholas J.;
    • Mwangi, Raphael;
    • Robinson, Dennis P.;
    • Allmer, Cristine;
    • Rosenthal, Allison C.;
    • Habermann, Thomas M.;
    • Feldman, Andrew L.;
    • Rimsza, Lisa M.;
    • King, Rebecca L.;
    • Larson, Melissa C.;
    • Negaard, Bri J.;
    • Norman, Aaron D.;
    • Rajkumar, Nikhil;
    • Ansell, Stephen M.;
    • Dispenzieri, Angela;
    • Murray, David L.;
    • Rajkumar, Vincent;
    • Kumar, Shaji;
    • Abeykoon, Jithma P.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    30

    Genetics and pathologic landscape of lineage switch of acute leukemia during therapy.

    Published in:
    Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-00983-2
    By:
    • Zhou, Ting;
    • Curry, Choladda V.;
    • Khanlari, Mahsa;
    • Shi, Min;
    • Cui, Wei;
    • Peker, Deniz;
    • Chen, Weina;
    • Wang, Endi;
    • Gao, Juehua;
    • Shen, Qi;
    • Xie, Wei;
    • Jelloul, Fatima Z.;
    • King, Rebecca L.;
    • Yuan, Ji;
    • Wang, Xiaoqiong;
    • Zhao, Chen;
    • Obiorah, Ifeyinwa E.;
    • Courville, Elizabeth L.;
    • Nomura, Eric;
    • Cherian, Sindhu
    Publication type:
    Article
    31

    Unraveling the genomic underpinnings of unbalanced MYC break-apart FISH results using whole genome sequencing analysis.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00967-8
    By:
    • Gagnon, Marie-France;
    • Penheiter, Alan R.;
    • Harris, Faye;
    • Sadeghian, Dorsay;
    • Johnson, Sarah H.;
    • Karagouga, Giannoula;
    • McCune, Alexa;
    • Zepeda-Mendoza, Cinthya;
    • Greipp, Patricia T.;
    • Xu, Xinjie;
    • Ketterling, Rhett P.;
    • McPhail, Ellen D.;
    • King, Rebecca L.;
    • Peterson, Jess F.;
    • Vasmatzis, George;
    • Baughn, Linda B.
    Publication type:
    Article
    32

    PET2 response associated with survival in newly diagnosed diffuse large B-cell lymphoma: results of two independent prospective cohorts.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 5, p. 1, doi. 10.1038/s41408-022-00649-x
    By:
    • Desai, Sanjal H.;
    • Pederson, Levi;
    • LaPlant, Betsy;
    • Mwangi, Raphael;
    • Maurer, Matthew;
    • Young, Jason R.;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Cerhan, James R.;
    • Feldman, Andrew;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    33

    Chronic lymphocytic leukemia (CLL) with Reed–Sternberg-like cells vs Classic Hodgkin lymphoma transformation of CLL: does this distinction matter?

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41408-022-00616-6
    By:
    • King, Rebecca L.;
    • Gupta, Alia;
    • Kurtin, Paul J.;
    • Ding, Wei;
    • Call, Timothy G.;
    • Rabe, Kari G.;
    • Kenderian, Saad S.;
    • Leis, Jose F.;
    • Wang, Yucai;
    • Schwager, Susan M.;
    • Slager, Susan L.;
    • Kay, Neil. E.;
    • Koehler, Amber;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Habermann, Thomas M.;
    • Shi, Min;
    • Hanson, Curtis A.;
    • Howard, Matthew T.;
    • Parikh, Sameer A.
    Publication type:
    Article
    34
    35

    Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 9, p. 1, doi. 10.1038/s41408-021-00542-z
    By:
    • Desai, Sanjal H.;
    • LaPlant, Betsy;
    • Macon, William R.;
    • King, Rebecca L.;
    • Wang, Yucai;
    • Inwards, David J.;
    • Micallef, Ivana;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    36

    Patterns of therapy initiation during the first decade for patients with follicular lymphoma who were observed at diagnosis in the rituximab era.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 7, p. 1, doi. 10.1038/s41408-021-00525-0
    By:
    • Arushi Khurana;
    • Mwangi, Raphael;
    • Ansell, Stephen M.;
    • Habermann, Thomas M.;
    • Cerhan, James R.;
    • Strouse, Christopher;
    • Link, Brian K.;
    • Wang, Yucai;
    • King, Rebecca L.;
    • Macon, William R.;
    • Villasboas, J. C.;
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Nowakowski, Grzegorz S.
    Publication type:
    Article
    37

    Somatic copy number gains in MYC, BCL2, and BCL6 identifies a subset of aggressive alternative-DH/TH DLBCL patients.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 11, p. 1, doi. 10.1038/s41408-020-00382-3
    By:
    • Krull, Jordan E.;
    • Wenzl, Kerstin;
    • Hartert, Keenan T.;
    • Manske, Michelle K.;
    • Sarangi, Vivekananda;
    • Maurer, Matthew J.;
    • Larson, Melissa C.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • McPhail, Ellen;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • King, Rebecca L.;
    • Cerhan, James R.;
    • Novak, Anne J.
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44

    Mastocytosis.

    Published in:
    2021
    By:
    • Tzankov, Alexandar;
    • Duncavage, Eric;
    • Craig, Fiona E;
    • Kelemen, Katalin;
    • King, Rebecca L;
    • Orazi, Attilio;
    • Quintanilla-Martinez, Leticia;
    • Reichard, Kaaren K;
    • Rimsza, Lisa M;
    • Wang, Sa A;
    • Horny, Hans-Peter;
    • George, Tracy I
    Publication type:
    journal article
    45
    46
    47
    48

    Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?

    Published in:
    2018
    By:
    • Fang, Hong;
    • Kapoor, Prashant;
    • Gonsalves, Wilson I;
    • Frederick, Lori A;
    • Viswanatha, David;
    • Howard, Matthew T;
    • He, Rong;
    • Morice, William G;
    • McPhail, Ellen D;
    • Greipp, Patricia T;
    • Morice, William G 2nd;
    • Ansell, Stephen M;
    • Kyle, Robert A;
    • Gertz, Morie A;
    • Paludo, Jonas;
    • Abeykoon, Jithma;
    • King, Rebecca L
    Publication type:
    journal article
    49

    Cryoablation for unresectable unicentric Castleman disease.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 1, p. 149, doi. 10.1002/ajh.27507
    By:
    • Nishimura, Yoshito;
    • Atwell, Thomas;
    • Callstrom, Matthew;
    • McGarrah, Patrick;
    • Howard, Matthew;
    • King, Rebecca L.;
    • Dispenzieri, Angela
    Publication type:
    Article
    50

    Survival trends in young patients with Waldenström macroglobulinemia: Over five decades of experience.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 3, p. 432, doi. 10.1002/ajh.26807
    By:
    • Chohan, Karan L.;
    • Paludo, Jonas;
    • Vallumsetla, Nishanth;
    • Larson, Dirk;
    • King, Rebecca L.;
    • He, Rong;
    • Gonsalves, Wilson;
    • Inwards, David;
    • Witzig, Thomas E.;
    • Swaika, Abhisek;
    • Jain, Tania;
    • Leung, Nelson;
    • Ailawadhi, Sikander;
    • Reeder, Craig B.;
    • Lacy, Martha Q.;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji;
    • Kyle, Robert A.;
    • Gertz, Morie A.;
    • Ansell, Stephen M.
    Publication type:
    Article